share_log

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4：持股變動聲明-董事 Lewis-Hall Freda C
美股SEC公告 ·  11/21 05:33

牛牛AI助理已提取核心訊息

Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.
Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.
Freda C. Lewis-Hall報告稱，她在Conduit Pharmaceuticals (CDt.US)公司的股份有重大收購。2024年11月18日，Lewis-Hall以每股0.0919美元的價格購買了437,976股普通股。在此交易之後，她直接持有437,976股。此外，根據交易報告，她在該公司擁有2,520,311股的間接受益所有權。該交易已被標記爲已完成。
Freda C. Lewis-Hall報告稱，她在Conduit Pharmaceuticals (CDt.US)公司的股份有重大收購。2024年11月18日，Lewis-Hall以每股0.0919美元的價格購買了437,976股普通股。在此交易之後，她直接持有437,976股。此外，根據交易報告，她在該公司擁有2,520,311股的間接受益所有權。該交易已被標記爲已完成。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間